Prostate cancer is the second leading cause of cancer death in men in the United States.
Androgen deprivation therapy (ADT) is currently the primary treatment for metastatic prostate …

Prostate cancer is the most common form of cancer diagnosed in men. Androgen
deprivation therapy (ADT) is commonly prescribed, with some estimates indicating over 50 …

Androgen deprivation therapy (ADT) is used to block the release of androgen in prostate
cancer to promote the regression of cancer cells, and hence, disease progression. Its …

Objectives Androgen deprivation therapy (ADT; also known as hormone therapy) is a well-
established treatment for prostate cancer patients with rising prostate-specific antigen levels …

Prostate cancer is the second most common form of cancer in men. For advanced, high risk
prostate cancer, androgen deprivation therapy (ADT) is the preferred treatment and can …

Purpose Although androgen deprivation therapy is widely used to treat prostate cancer, its
effects on cognitive function are unclear. To our knowledge no prior report has examined the …

Purpose To evaluate the effects of androgen-deprivation therapy (ADT) on cognitive function
in men with nonmetastatic prostate cancer (PC). Patients and Methods The following three …

The relationship between cognitive decline and androgen deprivation therapy (ADT) under
luteinizing hormone-releasing hormone (LHRH) analogues is unclear, and there is a …

Prostate cancer (PCa) is one of the most prevalent malignancies affecting males worldwide.
Despite reductions in mortality rates due to advances in early identification and treatment …

PURPOSE: Many patients with prostate cancer receive androgen deprivation therapy for
long periods. We compared physical and cognitive function, and quality of life in a cross …